Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Luckily for you, StockStory helps you navigate which companies are truly worth holding. Keeping that in mind, here is one low-volatility stock that could offer consistent gains and two stuck in limbo.
Two Stocks to Sell:
Rush Enterprises (RUSHA)
Rolling One-Year Beta: 0.92
Headquartered in Texas, Rush Enterprises (NASDAQ: RUSH.A) provides truck-related services and solutions, including sales, leasing, parts, and maintenance for commercial vehicles.
Why Do We Avoid RUSHA?
- Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last two years
- Forecasted revenue decline of 3.6% for the upcoming 12 months implies demand will fall off a cliff
- Sales over the last two years were less profitable as its earnings per share fell by 12% annually while its revenue was flat
Rush Enterprises is trading at $55.63 per share, or 17.5x forward P/E. Read our free research report to see why you should think twice about including RUSHA in your portfolio.
Globe Life (GL)
Rolling One-Year Beta: 0.42
With roots dating back to 1900 and a rebranding from Torchmark Corporation in 2019, Globe Life (NYSE: GL) is an insurance holding company that offers life insurance, supplemental health insurance, and annuity products through various distribution channels.
Why Are We Cautious About GL?
- Muted 4.5% annual revenue growth over the last two years shows its demand lagged behind its insurance peers
- 4.6% annualized net premiums earned growth over the last two years lagged behind its insurance peers
- Policy losses and capital returns have eroded its book value per share this cycle as its book value per share declined by 2% annually over the last five years
Globe Life’s stock price of $141.68 implies a valuation ratio of 2x forward P/B. Dive into our free research report to see why there are better opportunities than GL.
One Stock to Watch:
Elevance Health (ELV)
Rolling One-Year Beta: 0.28
Formerly known as Anthem until its 2022 rebranding, Elevance Health (NYSE: ELV) is one of America's largest health insurers, serving approximately 47 million medical members through its network-based managed care plans.
Why Could ELV Be a Winner?
- Annual revenue growth of 10.7% over the last five years was above the sector average and underscores its products and services value to customers
- Massive revenue base of $193.3 billion gives it meaningful leverage when negotiating reimbursement rates
- Industry-leading 27.7% return on capital demonstrates management’s skill in finding high-return investments
At $351.73 per share, Elevance Health trades at 12.8x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free for active Edge members.
High-Quality Stocks for All Market Conditions
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today.
